Notice of Kidney Interagency Coordinating Committee Meeting, 43218 [2013-17360]
Download as PDF
43218
Federal Register / Vol. 78, No. 139 / Friday, July 19, 2013 / Notices
Collaborative Research Opportunity:
The NCI Center for Cancer Research
Nanobiology is seeking statements of
capability or interest from parties
interested in collaborative research to
further develop, evaluate or
commercialize diagnostic or therapeutic
RNA nanoparticles. For collaboration
opportunities, please contact John
Hewes, Ph.D. at hewesj@mail.nih.gov.
Dated: July 12, 2013.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2013–17319 Filed 7–18–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Kidney Interagency
Coordinating Committee Meeting
The Kidney Interagency
Coordinating Committee (KICC) will
hold a meeting on September 27, 2013,
about interagency collaboration to
improve outcomes in Chronic Kidney
Disease (CKD). The meeting is open to
the public.
DATES: The meeting will be held on
September 27, 2013, 9 a.m. to 12 p.m.
Individuals wanting to present oral
comments must notify the contact
person at least 10 days before the
meeting date.
ADDRESSES: The meeting will be held at
the Natcher Conference Center (Building
45), on the NIH Campus at 8600
Rockville Pike, Bethesda, MD 20894.
FOR FURTHER INFORMATION CONTACT: For
further information concerning this
meeting, contact Dr. Andrew S. Narva,
Executive Secretary of the Kidney
Interagency Coordinating Committee,
National Institute of Diabetes and
Digestive and Kidney Diseases, 31
Center Drive, Building 31A, Room
9A26, MSC 2560, Bethesda, MD 20892–
2560, telephone: 301–594–8864; FAX:
301–480–0243; email:
nkdep@info.niddk.nih.gov.
SUPPLEMENTARY INFORMATION: The KICC,
chaired by the National Institute of
Diabetes and Digestive and Kidney
Diseases (NIDDK), comprises members
of the Department of Health and Human
Services and other federal agencies that
support kidney-related activities,
facilitates cooperation, communication,
and collaboration on kidney disease
among government entities. KICC
meetings, held twice a year, provide an
opportunity for Committee members to
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:33 Jul 18, 2013
Jkt 229001
learn about and discuss current and
future kidney programs in KICC member
organizations and to identify
opportunities for collaboration. The
September 27, 2013 KICC meeting will
focus on interagency collaboration to
improve outcomes in CKD.
Any member of the public interested
in presenting oral comments to the
Committee should notify the contact
person listed on this notice at least 10
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present;
oral comments and presentations will be
limited to a maximum of 5 minutes.
Printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
meeting, oral comments will be allowed
on a first-come, first-serve basis.
Members of the public who would
like to receive email notification about
future KICC meetings should send a
request to nkdep@info.niddk.nih.gov.
Dated: July 8, 2013.
Camille Hoover,
Executive Officer, National Institute of
Diabetes and Digestive and Kidney Diseases,
National Institutes of Health.
[FR Doc. 2013–17360 Filed 7–18–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
PO 00000
Frm 00079
Fmt 4703
Sfmt 9990
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Immune Mechanism.
Date: July 30, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Scott Jakes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892, 301–495–
1506, jakesse@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
13–005: Restoration of New Investigator Pilot
Projects Adversely Affected by Hurricane
Sandy.
Date: August 14, 2013.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Weihua Luo, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, (301) 435–
1170, luow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Vascular
Hematology.
Date: August 14, 2013.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Bukhtiar H Shah, DVM,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4120,
MSC 7802, Bethesda, MD 20892, 301–806–
7314, shahb@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 15, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–17320 Filed 7–18–13; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\19JYN1.SGM
19JYN1
Agencies
[Federal Register Volume 78, Number 139 (Friday, July 19, 2013)]
[Notices]
[Page 43218]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-17360]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Kidney Interagency Coordinating Committee Meeting
SUMMARY: The Kidney Interagency Coordinating Committee (KICC) will hold
a meeting on September 27, 2013, about interagency collaboration to
improve outcomes in Chronic Kidney Disease (CKD). The meeting is open
to the public.
DATES: The meeting will be held on September 27, 2013, 9 a.m. to 12
p.m. Individuals wanting to present oral comments must notify the
contact person at least 10 days before the meeting date.
ADDRESSES: The meeting will be held at the Natcher Conference Center
(Building 45), on the NIH Campus at 8600 Rockville Pike, Bethesda, MD
20894.
FOR FURTHER INFORMATION CONTACT: For further information concerning
this meeting, contact Dr. Andrew S. Narva, Executive Secretary of the
Kidney Interagency Coordinating Committee, National Institute of
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building
31A, Room 9A26, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-594-
8864; FAX: 301-480-0243; email: nkdep@info.niddk.nih.gov.
SUPPLEMENTARY INFORMATION: The KICC, chaired by the National Institute
of Diabetes and Digestive and Kidney Diseases (NIDDK), comprises
members of the Department of Health and Human Services and other
federal agencies that support kidney-related activities, facilitates
cooperation, communication, and collaboration on kidney disease among
government entities. KICC meetings, held twice a year, provide an
opportunity for Committee members to learn about and discuss current
and future kidney programs in KICC member organizations and to identify
opportunities for collaboration. The September 27, 2013 KICC meeting
will focus on interagency collaboration to improve outcomes in CKD.
Any member of the public interested in presenting oral comments to
the Committee should notify the contact person listed on this notice at
least 10 days in advance of the meeting. Interested individuals and
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the meeting. Only one
representative of an organization will be allowed to present; oral
comments and presentations will be limited to a maximum of 5 minutes.
Printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
Committee by forwarding their statement to the contact person listed on
this notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person. Because of time constraints for the meeting,
oral comments will be allowed on a first-come, first-serve basis.
Members of the public who would like to receive email notification
about future KICC meetings should send a request to
nkdep@info.niddk.nih.gov.
Dated: July 8, 2013.
Camille Hoover,
Executive Officer, National Institute of Diabetes and Digestive and
Kidney Diseases, National Institutes of Health.
[FR Doc. 2013-17360 Filed 7-18-13; 8:45 am]
BILLING CODE 4140-01-P